Inaugural Event Provided Startup Businesses Unprecedented Access to Venture and Investment Industry Experts
ExpressCells was named the top life sciences company–and one of the top three winners–in an inaugural National Venture Plan Competition (NVPC) by Pismo Ventures, which provided unprecedented, once-in-a-lifetime access for 197 startups to more than 160 investors, from 42 VCs and Angel investment groups serving as competition judges.
“Our goal was to provide a truly unique competition for startup businesses unlike any that has happened before, launching an event like this, in the middle of a worldwide pandemic makes it even more impactful,” said JJ Richa, CEO of Pismo Ventures and the founder of the NVPC.
Better Knock-ins, Better Cell Lines, Better Science
ExpressCells leverages proprietary gene-editing tools to customize human cell lines for drug discovery, toxicology, and other biologic research.